Grave' Disease
Showing 9976 - 10000 of >10,000
Cardiovascular Risk Factor, Stress, Self Efficacy Trial in Cincinnati (B-SWELL: Midlife Black Women's Stress Reduction Wellness
Completed
- Cardiovascular Risk Factor
- +4 more
- B-SWELL: Midlife Black Women's Stress Reduction Wellness Program
- WE: Wellness program for Midlife Black Women
-
Cincinnati, OhioUniversity of Cincinnati, College of Nursing
Jul 30, 2022
Dementia, Neurocognitive Disorders, Cognitive Impairment Trial in Portugal (Cognitive stimulation)
Recruiting
- Dementia
- +4 more
- Cognitive stimulation
-
Mealhada, Aveiro, Portugal
- +23 more
Jul 31, 2022
Survivors of Transplant, CREST Study
Recruiting
- Acute Lymphoblastic Leukemia
- +6 more
- Bioelectric Impedance Analysis
- +7 more
-
Duarte, CaliforniaCity of Hope Comprehensive Cancer Center
Mar 7, 2022
Low Back Pain, Mechanical, Chronic Low-back Pain, Mechanical Low Back Pain Trial in Karachi (Pressure Biofeedback Therapy +
Recruiting
- Low Back Pain, Mechanical
- +7 more
- Pressure Biofeedback Therapy + Progressive Muscles Relaxation + thermotherapy
- Progressive Muscles Relaxation + thermotherapy
-
Karachi, Sindh, PakistanDow Institute of Physical Medicine and Rehabilitation, DUHS.
Nov 14, 2022
HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2-positive Metastatic Breast Cancer Trial in Germany, Spain,
Recruiting
- HER2-positive Breast Cancer
- +4 more
-
Essen, Germany
- +5 more
Nov 15, 2022
Posture on Cognitive Function in Early Adolescence Athletes
Completed
- Posture
- Cognitive Function
- The effect of posture on cognitive function in early adolescence athletes
-
Ankara, TurkeyAtılım University
Jun 13, 2023
Gonarthrosis Trial in Istanbul (Exercise, Topical Diclofenac, Platelet-Rich-Plasma (PRP))
Not yet recruiting
- Gonarthrosis
- Exercise
- +2 more
-
Istanbul, TurkeyIstanbul University-Cerrahpasa
May 17, 2023
Moyamoya Trial in London (near infrared spectroscopy)
Suspended
- Moyamoya
- near infrared spectroscopy
-
London, United KingdomGreat Ormond Street Hospital for Children NHS Foundation Trust
Dec 2, 2021
Early and Sustained Pain Control in Radiographic Axial
Recruiting
- Radiographic Axial Spondylarthritis (r-axSpA)
-
La Plata, Buenos Aires, Argentina
- +162 more
Jan 12, 2023
Sjogren's Syndrome Trial in Reims (Evaluation of olfactory function, Evaluation of taste function, Evaluation of (intra-nasal
Not yet recruiting
- Sjogren's Syndrome
- Evaluation of olfactory function
- +2 more
-
Reims, FranceUniversité de Reims Champagne-Ardenne
May 24, 2022
Obstructive Sleep Apnea Trial (Smart Sleep Apnea Self-management Support Programme (4S), General Hygiene Information (GH))
Not yet recruiting
- Obstructive Sleep Apnea
- Smart Sleep Apnea Self-management Support Programme (4S)
- General Hygiene Information (GH)
- (no location specified)
May 23, 2022
Scoliosis, Juvenile Idiopathic Arthritis Trial in I?stanbul (Schroth 3-Dimensional scoliosis exercise, conventional scoliosis
Active, not recruiting
- Scoliosis
- Juvenile Idiopathic Arthritis
- Schroth 3-Dimensional scoliosis exercise
- conventional scoliosis exercise
-
İ̇stanbul, TurkeyEylül Pınar Kısa
Jan 22, 2023
Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis Trial in United States (Biospecimen
Recruiting
- Recurrent Langerhans Cell Histiocytosis
- Refractory Langerhans Cell Histiocytosis
- Biospecimen Collection
- +8 more
-
Wilmington, Delaware
- +3 more
Apr 28, 2023
Viral Hepatitis B, Viral Hepatitis D, Cirrhosis, Liver Trial in Worldwide (REP 2139-Mg, Tenofovir Disoproxil Fumarate, Pegylated
Available
- Viral Hepatitis B
- +6 more
- REP 2139-Mg
- +2 more
-
Vienna, Austria
- +12 more
Feb 1, 2023
Safety of Exposure to Natalizumab During Pregnancy
Recruiting
- Multiple Sclerosis
- Questionnaire
-
Besançon, France
- +26 more
Jun 27, 2022
Atherosclerotic Cardiovascular Disease, Older Patients, LDL Cholesterol Trial (Achieving a Target LDL-C level of 25mg/dL=
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- +2 more
- Achieving a Target LDL-C level of 25mg/dL≤ LDL-C<70mg/dL
- Achieving a Target LDL-C level of 70mg/dL≤ LDL-C<100mg/dL
- (no location specified)
Mar 14, 2023
Crohn Disease Trial in Rochester (Sulfur Hexafluoride, Ultrasound Elastography, Ultrasound Vascularity)
Terminated
- Crohn Disease
- Sulfur Hexafluoride
- +3 more
-
Rochester, MinnesotaMayo Clinic
Oct 15, 2021
Hidradenitis Suppurativa Trial in Barrie, Newmarket (Spesolimab Formulation 1, Spesolimab Formulation 2, Placebo matching
Recruiting
- Hidradenitis Suppurativa
- Spesolimab Formulation 1
- +3 more
-
Barrie, Ontario, Canada
- +1 more
Apr 19, 2023
Non-Alcoholic Fatty Liver Disease, Obesity Trial in Ras Al Khaimah (POSE2.0 procedure, Life style and behavioral intervention)
Completed
- Non-Alcoholic Fatty Liver Disease
- Obesity
- POSE2.0 procedure
- Life style and behavioral intervention
-
Ras Al Khaimah, United Arab EmiratesObaidulla Hospital, Emirates Health Services, Ministry of Health
Nov 3, 2022
Coronary Artery Disease Trial in Germany (Vericiguat (BAY1021189), Placebo, Isosorbide mononitrate (ISMN))
Completed
- Coronary Artery Disease
- Vericiguat (BAY1021189)
- +2 more
-
Bad Krozingen, Baden-Württemberg, Germany
- +5 more
Dec 9, 2021
Pediatric Acute Myelogenous Leukemia (AML) Trial in Australia, Canada, United States (Decitabine)
Terminated
- Pediatric Acute Myelogenous Leukemia (AML)
-
Phoenix, Arizona
- +21 more
Jun 24, 2022
Post ICU Syndrome, Chronic Pain, Covid-19 Trial in Barcelona (Intervention program)
Completed
- Post ICU Syndrome
- +2 more
- Intervention program
-
Barcelona, SpainTomás Cuñat
Dec 13, 2021
CKD (Chronic Kidney Disease) Stage 5D Trial in China (Aspirin 100 mg Oral Tablet)
Recruiting
- CKD (Chronic Kidney Disease) Stage 5D
- Aspirin 100 mg Oral Tablet
-
Fuzhou, Fujian, China
- +66 more
Jan 6, 2022